Adagio Medical Holdings Inc (ADGM)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$0.56+4.31%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · ADGM
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 3.6% |
| Our one-year growth estimate | diamond | Not available |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 87 industry peers · Company calendar date is not available
ADGM — legal / regulatory event — Notice of Delisting or Failure to Satisfy a Continued
Dated 2026-08-14
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Stockholders’ Equity Requirement On August 13, 2026, Adagio Medical Holdings, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule…
Why it matters: Earnings results show how well the company is doing. They reveal its financial and operational health.
Watch forThe earnings report shows if revenue is growing. It compares financial numbers to past quarters.
Also watch forEarnings report shows ongoing losses or falling revenue.
Why it matters: The company received a notice of non-compliance. This is critical for its listing status.
Worry ifA press release confirming compliance with Nasdaq listing rules by the next earnings date.
Less concerning ifThere are no updates on compliance. No notices of delisting before the next earnings date.
Why it matters: Reducing net losses is crucial for improving earnings per share and overall health.
Supportive ifNet loss decreases from $7.0 million in Q1 to less than $6.5 million in Q2.
Worry ifNet loss increases or stays at $7.0 million or worse in Q2.
Why it matters: Earnings results will show financial health and progress. This is important for how investors feel.
Watch forQ2 earnings show reduced net losses or improved cash flow.
Also watch forThe Q2 earnings report shows bigger net losses or worse cash flow.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$262 on $10,000 · ±2.6% | How much price usually moves either way. |
| Bad day | $960 loss on $10,000 · 9.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $8,413 loss on $10,000 · 84.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Higher operating income helps the company stay stable. It shows the company is improving.
Supportive ifOperating income goes from negative $5.2 million in Q1 to less negative in Q2.
Worry ifOperating income worsens or remains at negative $5.2 million or worse in Q2.
Why it matters: Not following rules could lead to delisting. This would hurt investor confidence and stock price.
Worry ifAdagio solves Nasdaq compliance issues and keeps its listing.
Less concerning ifAdagio does not meet Nasdaq compliance rules, leading to delisting.
Why it matters: Earnings results will show financial health and progress in operations.
Watch forEarnings report shows higher revenue or smaller losses than before.
Also watch forEarnings report shows ongoing losses or falling revenue.
Why it matters: Consistent results would strengthen the case for ULTA technology and support future sales. This is key for investor confidence.
Supportive ifFULCRUM-VT trial results show 84% freedom from ICD shock and 2.4% major adverse events in subsequent reports.
Worry ifNew data from the trial shows a significant increase in major adverse events or lower freedom from ICD shock.
Why it matters: FDA approval would confirm Adagio's technology. It would also allow the sale of its products.
Supportive ifFDA grants approval for the vCLAS system by Q4 2026.
Worry ifFDA denies approval or delays the decision beyond Q4 2026.
Why it matters: Keeping cash burn steady is important. It helps with financial health and smooth operations.
Worry ifQuarterly cash burn decreases to below $5 million.
Less concerning ifCash burn has been over $6 million for several quarters in a row.